Megan Fondren
Physician Assistant · Montrose, MINPI 1528347317
Payments from drug & device makers
Across 322 payments — averaging $17.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Novo Nordisk$880
- Novartis$622
- Amgen$514
- AbbVie$415
- GSK$270
- plus $2K from 24 others
What the payments were for
- Food & beverage$5,66499%
- Education$791%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 35 | $1,088 |
| Novo Nordisk | 66 | $880 |
| Novartis | 35 | $622 |
| Amgen | 35 | $514 |
| AbbVie | 28 | $415 |
| GSK | 21 | $270 |
| Otsuka America Pharmaceutical, Inc. | 12 | $229 |
| Lilly USA, LLC | 13 | $209 |
| Bayer | 11 | $197 |
| Axsome Therapeutics, Inc. | 6 | $143 |
| Boehringer Ingelheim | 7 | $142 |
| Lundbeck LLC | 6 | $131 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $106 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $100 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $82 |
| Pfizer | 5 | $80 |
| Xeris Pharmaceuticals, Inc. | 4 | $74 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $59 |
| Abbott | 3 | $57 |
| Sanofi-aventis U.S. LLC | 3 | $53 |
| Amarin Pharma, Inc. | 3 | $48 |
| Merck | 2 | $41 |
| Nestle Healthcare Nutrition Inc. | 2 | $40 |
| Esperion Therapeutics, Inc. | 2 | $37 |
| Harmony Biosciences LLC | 1 | $32 |
| Corcept Therapeutics | 1 | $24 |
| Ardelyx, Inc. | 1 | $19 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| Exact Sciences | 1 | $18 |
| Intra-sana Laboratories | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,743 in reported general payments places this provider in the 95th percentile of 5,453 physician assistant providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 143 | $182,050 |
| JardianceEmpagliflozin | 97 | $133,703 |
| TrulicityDulaglutide | 60 | $128,457 |
| OzempicSemaglutide | 90 | $126,167 |
| MounjaroTirzepatide | 106 | $118,673 |
| FarxigaDapagliflozin Propanediol | 90 | $99,573 |
| Repatha SureclickEvolocumab | 64 | $85,126 |
| EnbrelEtanercept | 11 | $79,303 |
| EliquisApixaban | 65 | $73,899 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 52 | $60,771 |
| XareltoRivaroxaban | 38 | $46,309 |
| Xigduo XrDapaglifloz Propaned/Metformin | 23 | $29,110 |
| ZenpepLipase/Protease/Amylase | 13 | $27,135 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 23 | $22,777 |
| JanuviaSitagliptin Phosphate | 15 | $22,637 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $209 | $247,130166 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Arexvy | $270 | $200,126172 claims |
| Boehringer IngelheimJardiance | $142 | $133,70397 claims |
| Novo NordiskOzempic | $880 | $126,16790 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $1,088 | $122,350113 claims |
| AmgenEnbrel | $514 | $79,30311 claims |
| PfizerEliquis | $80 | $73,89965 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $53 | $60,77152 claims |
| AbbVieVraylar, Linzess | $415 | $28,04622 claims |
| MerckJanuvia | $41 | $22,63715 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $59 | $11,16816 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,453 physician assistant providers in Michigan.
Other physician assistant in Montrose
- Sarang PatelRoyal Oak$660K
- Beth SweneyAda$617K
- Zainab JishiCanton$596K
- Taylor HennrickAdrian$430K
- Erin van DykeGrand Rapids$346K
- Ashley AldridgeAnn Arbor$298K
- Derek SusallaRochester Hills$242K
- Gabrielle DamoreRoyal Oak$200K
- Melissa MickelsonKalamazoo$168K
- Patrick CooneyNew Baltimore$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.